Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 134-141

  Florez, Hermes ^a,b,c   Mendez, Armando ^a   Casanova Romero, Paul ^a,c   Larreal Urdaneta, Carmen ^a,c   Castillo Florez, Sumaya ^a,c   Lee, David ^a   Goldberg, Ronald ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Apolipoprotein C III; Diabetes; Dyslipidemia; Insulin resistance; Metabolic syndrome; Small dense low density lipoprotein

Indexed keywords

APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX ROLE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEIN C-III; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; ETHNIC GROUPS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARTICLE SIZE; RISK FACTORS; TRIGLYCERIDES;

EID: 33746521929     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.013     Document Type: Article

References (30)

1. McKeigue P.M., Laws A., Chen Y.D., Marmot M.G., and Reaven G.M. Relation of plasma triglyceride and apoB level to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern. Arterioscler Thromb 13 (1993) 1187-1192
2. Laws A., Hoen H.M., Selby J.V., Saad M.F., Haffner S.M., and Howard B.V. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol 17 (1997) 64-71
3. Stampfer M.J., Krauss R.M., Ma J., et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276 (1996) 882-888
4. Lamarche B., Tchernof A., Moorjani S., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95 (1997) 69-75
5. Tan K.C.B., Cooper M.B., Ling K.L.E., et al. Fasting and postprandial determinants for the occurrence of small-dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin-precursor species and insulin resistance. Atherosclerosis 113 (1995) 273-287
6. McNamara J.R., Campos H., Ordovas J.M., Peterson J., Wilson P.W., and Schaefer E.J. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 7 (1987) 483-490
7. Haffner S.M., D'Agostino R., Goff D., et al. LDL size in African-Americans, Hispanics, and non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol 19 (1999) 2234-2240
8. Wang C.-S., McConathy W.J., Kloer H.U., and Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75 (1985) 384-390
9. Sehayek E., and Eisenberg S. Mechanisms of inhibition of apolipoprotein C on apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 266 (1991) 18259-18267
10. Stalenhoef A.F., Demacker P.N., Lutterman J.A., and van't Laar A. Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Diabetologia 22 (1982) 489-491
11. Castro Cabezas M., de Bruin T.W.A., de Valk H.W., Shoulders C.C., Jansen H., and Erkelens D.W. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 92 (1993) 160-168
12. Bard J.M., Charles M.A., Juhan-Vague I., et al., The BIGPRO Study Group. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity. The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 Study. Arterioscler Thromb Vasc Biol 21 (2001) 407-414
13. Dallinga-Thie G.M., Groenendijk M., Blom R.N.H.H.C., De Bruin T.W.A., and De Kant E. Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin. J Lipid Res 42 (2001) 1450-1456
14. Packard C.J., Demant T., Stewart J.P., et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41 (2000) 305-317
15. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
16. Krauss R.M., and Burke D. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23 (1982) 97-104
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diab Care 26 (2003) 3160-3167
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart Study. Diab Care 20 (1997) 1087-1092
20. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
21. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 15 (1998) 539-553
22. Onat A., Hergenç G., Sansoy V., et al. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 168 (2003) 81-89
23. Olivieri O., Bassi A., Stranieri C., et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 44 (2003) 2374-2381
24. Windler E., and Havel R.J. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res 26 (1985) 556-565
25. Haffner S.M., Stern M.P., Hazuda H.P., Rosenthal M., and Knapp J.A. The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins. Am J Epidemiol 123 (1986) 830-839
26. Haffner S.M., Hazuda H.P., Mitchell B.D., Patterson J.K., and Stern M.P. Increased incidence of type II diabetes mellitus in Mexican Americans. Diab Care 14 (1991) 102-108
27. Freedman D.S., Strogatz D.S., Eaker E., Joesoef M.R., and DeStefano F. Differences between black and white men in correlates of high density lipoprotein cholesterol. Am J Epidemiol 132 (1990) 656-659
28. Le N.-A., Gibson J.C., and Ginsberg H.N. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. J Lipid Res 29 (1988) 669-677
29. Batal R., Tremblay M., Barrett P.H.R., et al. Plasma kinetics of apo C-III and apoE in normolipidemic and hypertriglyceridemic subjects. J Lipid Res 41 (2000) 706-718
30. Russo G.T., Meigs J.B., Cupples L.A., et al. Association of the Sst-I polymorphism at the apoC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158 (2001) 173-181